Sector pending / Medical LaboratoriesUpdated 2026-05-10 22:07 UTC

FRA/N6B stock hub

FRA/N6B has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/N6Bis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

17.7B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/N6B

In the news

Latest news · FRA/N6B

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E13.8

P25 n/aP50 n/aP75 n/a

Trailing P/E21.7

P25 n/aP50 n/aP75 n/a

ROE11

P25 n/aP50 n/aP75 n/a

ROIC8.6

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/N6B market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

221

Groups with data

Currency

USD

Showing 221 of 221 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	71,000
Employees Change	1,000%
Employees Change Percent	1.43
Enterprise value	EUR 23.1B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical Laboratories
Last refreshed	2026-05-10
Market cap	EUR 17.7B
Price	EUR 218
Price currency	EUR
Rev Per Employee	184,789.71x
Sic	8071
Symbol	fra/N6B
Website	https://www.labcorp.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.61%
EV Earnings	28.27x
EV/EBIT	17.62x
EV/EBITDA	10.69x
EV/FCF	19.23x
EV/Sales	1.92x
FCF yield	6.78%
Forward P/E	13.84x
P/B ratio	2.33x
P/E ratio	21.68x
P/S ratio	1.44x
PE Ratio10 Y	21.93x
PE Ratio3 Y	31.56x
PE Ratio5 Y	24.01x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	11.03%
EBITDA Margin	15.93%
FCF margin	9.78%
Gross margin	28.83%
Gross Profit	EUR 3.5B
Gross Profit Growth	10.97%
Gross Profit Growth Q	6.94%
Gross Profit Growth3 Y	5.46%
Gross Profit Growth5 Y	-6.88%
Net Income	EUR 816.6M
Net Income Growth	28.83%
Net Income Growth Q	30.55%
Net Income Growth3 Y	-2%
Net Income Growth5 Y	-18.65%
Pretax Margin	8.14%
Profit Margin	6.66%
Profit Per Employee	EUR 12,300
ROA	5.31
Roa5y	5.62
ROCE	9.48
ROE	11.05
Roe5y	11.24
ROIC	8.6
Roic5y	9.02

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	9.4%
Cagr15y	9.76%
Cagr1y	2.98%
Cagr3y	9.68%
Cagr5y	2.98%
Div CAGR3	-3.35%
EPS Growth	30.21
EPS Growth Q	32.94
EPS Growth3 Y	0.64
EPS Growth5 Y	-15.94
FCF Growth	20.14%
FCF Growth3 Y	7.24%
FCF Growth5 Y	-12.63%
OCF Growth	10.98%
OCF Growth Q	935.14%
OCF Growth10 Y	4.24%
OCF Growth3 Y	6.23%
OCF Growth5 Y	-10.1%
Revenue Growth	7.34x
Revenue Growth Q	5.76x
Revenue Growth3 Y	6.36x
Revenue Growth5 Y	-1.58x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.77
Assets	EUR 16.6B
Cash	EUR 850.9M
Current Assets	EUR 3.9B
Current Liabilities	EUR 2.2B
Debt	EUR 6.3B
Debt EBITDA	EUR 2.85
Debt Equity	EUR 0.83
Debt FCF	EUR 5.27
Equity	EUR 7.6B
Interest Coverage	6.99
Liabilities	EUR 9B
Long Term Assets	EUR 12.7B
Long Term Liabilities	EUR 6.7B
Net Cash	EUR -5.5B
Net Cash By Market Cap	EUR -30.93
Net Debt EBITDA	EUR 2.8
Net Debt Equity	EUR 0.72
Net Debt FCF	EUR 4.56
Tangible Book Value	EUR -1.6B
Tangible Book Value Per Share	EUR -19.63

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.73
Inventory Turnover	20.42
Net Working Capital	EUR 1.4B
Quick ratio	1.3
Working Capital	EUR 1.7B
Working Capital Turnover	EUR 6.73

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.01%
Dividend Growth	-7.21%
Dividend Growth Years	0%
Dividend per share	EUR 2.49
Dividend Years	5
Dividend Yield	1.14%
Ex Div Date	2026-02-27
Last Dividend	EUR 0.61
Payout Frequency	Quarterly
Payout Ratio	25.44%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	145.6%
1Y total return	2.98%
200-day SMA	228.6
3Y total return	31.96%
50-day SMA	229.4
50-day SMA vs 200-day SMA	50over200
5Y total return	15.82%
All Time High	276.9
All Time High Change	-21.27%
All Time High Date	2022-01-03
All Time Low	54.09
All Time Low Change	303.03%
All Time Low Date	2011-08-23
ATR	2.83
Ch YTD	2.83
High	218
High52	248
High52 Date	2025-10-21
High52ch	-12.1%
Low	218
Low52	206
Low52 Date	2025-07-22
Low52ch	5.83%
Ma50ch	-4.95%
Price vs 200-day SMA	-4.63%
RSI	41.94
RSI Monthly	49.58
RSI Weekly	42.53
Sharpe ratio	-0.03x
Sortino ratio	0.19
Total Return	2.15%
Tr YTD	3.1
Tr15y	304.07%
Tr1m	-7.63%
Tr3m	-6.6%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 1.4B
Operating Income Growth	36.64
Operating Income Growth Q	16.49
Operating Income Growth3 Y	1.73
Operating Income Growth5 Y	-16.43
Operating margin	11.03

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	81,596,940%
Net Borrowing	635,971,500
Shares Insiders	0.4%
Shares Institutions	103.83%
Shares Qo Q	-0.36%
Shares Yo Y	-1.01%
Short Ratio	4.82

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 1.1B
Average Volume	2.6x
Bv Per Share	91.98
CAPEX	EUR -372.5M
Ch10y	100.5
Ch15y	230
Ch1m	-7.63
Ch1y	1.87
Ch3m	-6.84
Ch3y	9
Ch5y	-5.42
Ch6m	2.83
Change	0.93%
Change From Open	0
Close	216
Days Gap	0.93
Depreciation Amortization	587,722,462.2
Earnings Date	2026-04-30
EBIT	EUR 1.4B
EBITDA	EUR 2B
EPS	EUR 9.79
F Score	5
FCF	EUR 1.2B
FCF EV Yield	5.2x
Financing CF	-31,916,640
Fiscal Year End	December
Founded	1,995
Goodwill	5,897,745,302.4
Graham Number	145.3625
Graham Upside	-33.32
Income Tax	EUR 181.5M
Investing CF	-1,023,500,730
Is Primary Listing	0
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Lynch Fair Value	EUR 50.27
Lynch Upside	-76.94
Ma150	227.9
Ma150ch	-4.34%
Ma20	223
Ma20ch	-2.24%
Net CF	530,527,410
Open	218
P FCF Ratio	14.75
P OCF Ratio	11.26
Payment Date	2026-03-12
Ppne	2,599,427,511
Price Date	2026-05-08
Price EBITDA	EUR 9.06
Relative Volume	0.8x
Revenue	12,267,264,660x
SBC By Revenue	0.88x
Share Based Comp	108,152,310
Tax By Revenue	1.48x
Tax Rate	18.17%
Tr6m	3.38%
Volume	0
Z Score	3.04

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/N6B dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.1%

$2.49 annual per share

Payout ratio

+25.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

+2.1%

Next ex-dividend date: 2026-02-27

Performance

FRA/N6B stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/N6B?

Insider, institutional, and short-interest positioning.

Institutional ownership

+103.8%

Share of float held by funds and institutions

Insider ownership

+0.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/N6B momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

41.9

Neutral momentum band

Price vs 200-day MA

-4.6%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.03

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/N6B

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/N6B stock rating?

fra/N6B is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/N6B analysis?

The full report lives at /stocks/fra/N6B/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/N6B?

The latest report frames fra/N6B around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/N6B page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.